TerminatedNCT03481959
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
Medication studyAges 12–25FranceADHD
Understand this study
Who could participate?
Listed age limits: 12 years to 25 years.
- Listed locations
- ParisSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 7, 2019
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 3
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France
- Age range
- From 12 Years to 25 Years
- Official registry ID
- NCT03481959
- Official title
Show the full official title
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Paris
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Assistance Publique - Hôpitaux de Paris.
Does this study involve medication?
Yes. The study involves medication, including Methylphenidate.
Who can participate?
Listed age limits: 12 years to 25 years.
Is this study still recruiting?
The registry lists this study as terminated.
